Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY: HIMS )

44.34 +1.79 (+4.21%)
Streaming Delayed Price Updated: 2:59 PM EST, Feb 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Hims & Hers to Announce Third Quarter 2022 Earnings on November 7, 2022
From Hims & Hers Health, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
Upgrades 
Via Benzinga
What 4 Analyst Ratings Have To Say About Hims & Hers Health
Over the past 3 months, 4 analysts have published their opinion on Hims & Hers Health (NYSE:HIMS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
4 Analysts Have This to Say About Hims & Hers Health
  Within the last quarter, Hims & Hers Health (NYSE:HIMS) has observed the following analyst ratings: 
Via Benzinga
Hims & Hers Health: Q2 Earnings Insights
  Hims & Hers Health (NYSE:HIMS) reported its Q2 earnings results on Monday, August 8, 2022 at 04:15 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Hims & Hers appoints Chief Communications Officer & VP of Fulfillment Operations
From Hims & Hers Health, Inc.
Via Business Wire
Now More Than Ever Americans Are Open To Exploring Their Sexuality, Hims & Hers’ Nationwide Survey Uncovers The Realities Of Sex In America Today
From Hims & Hers Health, Inc.
Via Business Wire
What 4 Analyst Ratings Have To Say About Hims & Hers Health
Over the past 3 months, 4 analysts have published their opinion on Hims & Hers Health (NYSE:HIMS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Upgrades 
Via Benzinga
Hims & Hers Launches New Android Apps
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health's Return on Invested Capital Overview
Benzinga Pro data, Hims & Hers Health (NYSE:HIMS) reported Q2 sales of $113.56 million. Earnings fell to a loss of $19.68 million, resulting in a 21.09% decrease from last quarter. 
Via Benzinga
What Is Going on With Teladoc (TDOC) Stock Today?
With Amazon dropping out of the telehealth business, Teladoc Health moved higher though TDOC stock may struggle longer term. 
Via InvestorPlace
Hims & Hers Health, Inc. Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Outlook
From Hims & Hers Health, Inc.
Via Business Wire
SVB Securities Sees 26% Downside In This Telehealth Platform
Via Benzinga
Hims & Hers Partners With Carbon Health
Hims & Hers Health Inc (NYSE: HIMS) has partnered with healthcare provider Carbon Health to enable access to a broader range of care options through its... 
Via Benzinga
Earnings Preview For Hims & Hers Health
Hims & Hers Health (NYSE:HIMS) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that Hims & Hers... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022
  
Via Benzinga
Hims & Hers Health, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 8, 2022
From Hims & Hers Health, Inc.
Via Business Wire
3 Stocks Under $5 Insiders Are Aggressively Buying
U.S. stocks closed sharply lower, with the Nasdaq Composite dipping around 450 on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
7 Penny Stocks That Actually Have Analyst Buy Ratings
Many penny stocks (stocks trading for less than $5 per share) have little analyst coverage, but these seven have sell-side "buy" ratings. 
Via InvestorPlace
Hims & Hers Announces 2022 Pride Tour Partnership with Drag Superstars Violet Chachki, Gottmik, and LGBTQ Youth Support Organization, The Trevor Project
From Hims & Hers
Via Business Wire
Hers Doubles Down On Commitment To Women’s Wellness With Launch of 6 New Hers Wellness Essentials Supplements
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health, Inc. Reports First Quarter 2022 Financial Results and Raises Full Year 2022 Revenue Outlook
From Hims & Hers Health, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 12.6% to $0.58 during Friday's after-market session. The market value of their outstanding shares is at $8.9 million. 
Via Benzinga
Earnings Preview For Hims & Hers Health
Hims & Hers Health (NYSE:HIMS) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Hims & Hers... 
Via Benzinga
This Company Is Reportedly Solving Bedroom Performance Issues Behind Closed Doors
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022
Upgrades 
Via Benzinga
Hims & Hers Health, Inc. to Announce First Quarter 2022 Financial Results and Host Conference Call on May 9, 2022
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers and Carbon Health Partner to Expand Care Options for California Customers
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health Expands Skincare Offerings
Hims & Hers Health Inc (NYSE: HIMS) has expanded its skincare collections, including a facial cleanser, moisturizer, daily SPF, spot corrector, and face oil.... 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.